Pexelizumab: Phase II

In the international, double-blind COMPLY trial in 920 treated patients who sustained an AMI and were treated with a

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE